AGS/AIBCããã€ã®æåã«ç¶ãã次ã®ãã©ãã°ã·ããã€ãã³ããSiGMAãã«ã¿ (2021幎11æ) ã«åããŠå
šåãå°œãããŠãããåºå±ã®10ã€ã®ã¡ãªãããäžèšã®ãªã¹ãã«ãŸãšãã:
1. SiGMAã¯ãæ°åã³ãããŠã€ã«ã¹ã®ãã³ããã㯠(äžçç倧æµè¡) ãçºçããŠä»¥æ¥åããŠã®å€§èŠæš¡ãªã²ãŒã ã·ã§ãŒãšãªã
ã»ãŒ2幎ã«åã¶ããŒãã£ã«ã€ãã³ããšããã€ã§ã®åã®åœé察é¢ã€ãã³ããçµãŠãSiGMAã埩掻ããæãæ¥ãŸãããSiGMAã¯ããã³ãããã¯ãå§ãŸã£ãŠä»¥æ¥åããŠã®å€§èŠæš¡ãªã²ãŒã ã·ã§ãŒãéå¬ããã
SiGMA Groupã¯å²äžåããŠããã¹ãŠã®ã«ã³ãã¡ã¬ã³ã¹ã®æ¯äœãšãªã4ã€ã®äž»èŠãªã·ã§ãŒããŸãšãããSiGMAã¯ãAGSãšAIBCãšå
±ã«ã16æ¥ãã11æ19æ¥ãŸã§ããã«ã¿åœéèŠæ¬åžã³ã³ãã³ã·ã§ã³ã»ã³ã¿ãŒ (MFCC) ã®ç¬¬1çš®äŒå Žã§ããžãã¹ã®æé«å³°ãæ«é²ããããšã«ãªãã
2. SiGMAã¯ãäžçæ倧ã®å±ç€ºäŒã§ãæ¥çå
šäœã®é¢å¿ã«å¿ãã
Malta Weekã¯ãæè³å®¶ãå€è§çãªããžãã¹ååŒã®å€§ããªå¯èœæ§ã掻çšããæ¥çã®äž»èŠãªã¢ãã£ãªãšã€ããæ¿çç«æ¡è
ãææ³çãªãŒããŒããµãã©ã€ã€ãŒããªãã¬ãŒã¿ãŒãšã€ãªããæ©äŒãåå¢ãããæ©äŒã§ããã
SiGMAã¯ãB2CããB2BãŸã§ã®ãã¹ãŠãã«ããŒããæ°èæè¡ãå«ãã²ãŒã æ¥çå
šäœã®é¢å¿ã«å¿ããäžçæ倧ã®ã·ã§ãŒã§ããã
3.ã¢ãã£ãªãšã€ãã®é¢ä¿ãè²ã
SiGMAã¯ãé¢ä¿äŒç€Ÿãšå®æçã«ã€ã³ã¿ãã¥ãŒãè¡ãã圌ãã®ä»äºãåºãäŒããåãªãã€ãªãããè¶
ããé·æçãªé¢ä¿ãç¯ããŠãããããã¯ãSiGMAã€ãã³ããæé·ã®ããã®æé©ãªæ©äŒãšãªãå Žæã§ããããšãç¥ã£ãŠããã¢ãã£ãªãšã€ããç§ãã¡ã®ã€ãã³ãã«çŸ€ãããšããæè¯ã®ã·ããªãªãäœãåºããã
4. AGSã¯SiGMAãšäžŠè¡ããŠéå¬ããã
ããã€ã§?Affiliate Grand Slam (AGS)ãæ£åŒã«ã¹ã¿ãŒãããããšã§ããã©ã³ãã¯èªç«ããæã
ã®äž»èŠãªããŒãã£ã«ã«åžå Žã®äžã€ãšãªããŸãããAdTechãDigital Marketingã«ãé²åºããããšã§ãã²ãŒã ã ãã§ãªãããããæ¥çã®ã¢ãã£ãªãšã€ãããæ°ããªè¡çµ±ãéãŸãããšã«ãªãã
ããã¯ããã«ãeã³ããŒã¹ãNutraãDatingãCryptoãFast Loansããã®ä»ã²ãŒã 以å€ã®åéãããæ¥ç·çã«é¢é£ããæ¥æé·ããŠããå€ãã®ã¢ãã£ãªãšã€ããéããŠããã
5. AIBCã®ããã«ãã£ãŠããæå·ã¢ãã£ãªãšã€ã
ããã€ã§AGSãšAIBCãããªããžããã®ã¯ç°¡åãªããšã ã£ãã®ã§ãSiGMAã¯åã³æå·é¢é£ã®ã¢ãã£ãªãšã€ããSiGMA Europeã«æåŸ
ããŸããããã3ã€ã®ç£æ¥ã®éã«ååšããèªç¶ãªååŠçæ§è³ªã«ãã£ãŠãäŒè°ãšå±ç€ºå Žã®äž¡æ¹ããåºåžããŠããææ³çæå°è
ãšèµ·æ¥å®¶ã®éã®ãã€ãããã¯ã§æµåçãªæèŠäº€æãäœãåºãããšãæŠç¥çã«ä¿èšŒããããšãã§ããã
6. ã¢ãã£ãªãšã€ãåãã®ãã«ãåçŽçã«ã³ãã¡ã¬ã³ã¹
å±ç€ºäŒä»¥å€ã«ããSiGMAã¯ããã€ãã®ããã«ãåå è
ãç§ãã¡ã®å€ãã®äºå®ãããããã«ãææºã«é¢ããåºèª¿è¬æŒã«è³ãåŸãããåå ãããããæ©äŒãæäŸããã§ããããé·å¹Žã«ããããSiGMAã¯ããŸããŸãªæ¥çã®å€§æäŒæ¥ãããŸããŸãªã·ã§ãŒã§çŽ¹ä»ããæ©äŒãšæ©äŒãåŸãŠããã
ä»åSiGMAã¯ãAGSãAIBCãMedTechã®åã«ã³ãã¡ã¬ã³ã¹ãšäžŠè¡ããŠç¬èªã®ã«ã³ãã¡ã¬ã³ã¹ãéå¬ãããããç¹ã«ã²ãŒã é¢é£äŒæ¥ã«ã¹ãããã©ã€ããåœãŠãæ©äŒãåŸãããšã«ãªããå
šéšã§4ã€ã®äŒè°ãéå¬!
7. ããžã¿ã«ããŒã±ãã£ã³ã°ãªã©ã«ç¹åããã¯ãŒã¯ã·ã§ãã
ãã®ã€ãã³ãã§ã¯ãè€æ°ã®ã¯ãŒã¯ã·ã§ããã«ãŒã ãæäŸããããšã«ãéç¹ã眮ãããŠãããè¬æŒè
ã®å€ãããæ¥çã®ããŸããŸãªåŽé¢ã«é¢ããæ°å€ãã®æè²è¬æŒããã¬ãŒã³ããŒã·ã§ã³ã§ã¡ã€ã³ã¹ããŒãžã«ç»å Žããäºå®ã
ããã€ãã®ãããã¯ã¯ã现éšã«è³ããŸã§ããå€ãã®æéãå¿
èŠãšããã®ã§ãSiGMAã¯ãçµéšãäžæ©é²ããŠãäž»èŠãªæ®µéã§è¡šçŸãããã¢ã€ãã¢ããã¹ãããããšãæã人ã
ã®ããã®ã¹ããŒã¹ãæäŸããã
8.ã€ãã³ãã¯ä»äºã®è¡äºã§ããããç¥ãã§ãã?
SiGMAã€ãã³ãã®å§åçãªå€§ããã¯ãå®éã«ä»äºé¢æ°ã«ããããšãããã«å¿ããããã»ã©ã§ãããå±å
å€ã®ã·ãŒã ã¬ã¹ãªãããã¯ãŒã¯ãšãããã¢ãå²ããã³ãã®è¯ãé°å²æ°ãããŸãã§ãç¥ãæ°åãçãäžããŠããã!ãäžçã²ãŒã ãã§ã¹ãã£ãã«ããšåŒã°ããŠãç¡é§ã§ã¯ãªãã
SiGMAã®çµéšã¯ã»ãŒ10幎éå¹ã£ãŠãããã®ã§ãæé«ã®ãããã¯ãŒãã³ã°ããã©ãŒãã³ã¹ãä¿èšŒãããšãšãã«ãéåžžã«æ¥œããä»å 䟡å€ãåããã
9.ãã«ã¿ã¯çŸ€å
ç«ã«éãã
ãã«ã¿ã®ä¿å¥å€§è£Chris Farenã¯ã5æã®æåŸã®é±ã«ããã«ã¿ã¯ãã®æ人人å£ã®70%ã«å°ãªããšã1åã®COVID-19ã®äºé²æ¥çš®ãããããããéå£å
ç«ãéæããæåã®æ¬§å·é£ååœã«ãªã£ããšè¿°ã¹ãã
SiGMAã®ããã€ã®ã€ãã³ãã¯ãé©åãªèšç»ãšå¥åº·ãšå®å
šã®æé ã§æåããã€ãã³ããçµç¹ããããšãå¯èœã§ããããšã蚌æããŠãããããã«ã¿ãã€ãã³ãäžã«éå£å
ç«ã«ãããšããäºå®ã¯ããããã¯ããã«è¯ããã!
10. ãã§ã€ã¹?ãã¥?ãã§ã€ã¹?ãããã¯ãŒãã³ã°
ãªã³ã©ã€ã³æ©èœã¯ãããé·ããªãŒããšãªãŒãçæã®ããã®ããå€ãã®æ段ãæäŸãããããããã¯ãŒã¯ã«é¢ããŠã¯ãå€ãè¯ããã³ãã·ã§ãŒã¯ã«åããã®ã¯ãªããããžãã¹äžã®é¢ä¿ã¯ä¿¡é Œã«äŸåããŠããã察é¢ã§ã®ãããã¯ãŒãã³ã°ãè¡ããããšä¿¡é Œã¯é«ãŸãã
ãªã³ã©ã€ã³ã§çµã°ããé¢ä¿ãæ£åŒã«ç¢ºç«ããå°æ¥ææãªæªæ¥ã«ã€ãªããå¯èœæ§ã®ããæ°ããé¢ä¿ãã¹ã¿ãŒããããæãæ¥ã!
ç¹å
ž: ã€ãã³ãã«ã¯SiGMAã®åŸ
æã®æ©èœããã¹ãŠå«ãŸãã
ã«ã³ãã¡ã¬ã³ã¹ã¯ããŠãããã€ãã³ãã«ã¯SiGMAãæäŸããæ¯é¡ã®ãªãäœéšã«äŒŽãåŸ
æã®æ©èœããã¹ãŠå«ãŸããããããã¯ãæ¥çã®ãããã倧æäŒæ¥ãéãŸãæé·æã®å±ç€ºããã¢ã§æ§æããããç§ãã¡ã®ãã¬ãŒãããŒã¯ã§ããã¹ã¿ãŒãã¢ããã®å£²ã蟌ã¿ããSiGMAãAGSãAIBCã®ã¹ã¿ãŒãã¢ããããããè³ãç®æããŠã¹ããŒãžã«æ»ã£ãŠããã ãããSiGMAã®æåãªæè³åŒã®å€ãã€ãã³ãã§å€§ããªåœ¹å²ãæããã®ã§ãã¹ã¿ãŒãã¢ãããšããŠèªãããããå¿åãããããã«å€ãã人ãå¿
ãæåããŠãã ãã!
ç¶ãã¯: ãã«ã¿?ãŠã£ãŒã¯
ãã«ã¿?ãŠã£ãŒã¯ (Malta Week) ã§ã¯ãçŽ æŽããããããã¯ãŒãã³ã°ã®æ©äŒããç¬å çãªæ¥çæ
å ±ããèŠéããªããæ¥çããªãŒããã4ã€ã®çªçµããããžãã¹ã®æé«ã®éšåãäžå ã«äŒããŸãããã«ã¿?ãŠã£ãŒã¯ã¯ãSiGMA,?AIBC,?Med-Tech World?ãš?AGSã®ã€ãã³ãã§æ§æãããããããã®äžå¿çãªç£æ¥ã®çºå±ã玹ä»ããã
åãã©ã³ãã®ã¯ãã¹ã³ã©ãã¬ãŒã·ã§ã³ã«ããããã«ã¿?ãŠã£ãŒã¯ã¯ã²ãŒã åéãæ°èãã¯ãããžãŒãããžã¿ã«ãã«ã¹ãããžã¿ã«ããŒã±ãã£ã³ã°ã®å€§æã·ã³ã¯ã¿ã³ã¯ã®ãã³ããŒã¯ã³ã®ç®çå°ãšãªã£ãŠãããå°äžæµ·ã®çãäžã¯ãå€è§çãªããžãã¹ååŒãäž»èŠãªå ççµç¹ãæ¿çç«æ¡è
ãææ³æå°è
ãšã®çŽæ¥å¯Ÿè©±ã«æé©ãªå Žæã§ããã